Associate Professor Helmut Schaider
Associate Professor

Helmut Schaider

Email: 
Phone: 
+61 7 344 38027

Availability

Associate Professor Helmut Schaider is:
Available for supervision

Qualifications

  • Bachelor of Medicine, Karl-Franzens- Universität Graz
  • Certificate of Dermatology, Australasian College of Dermatologists

Search Professor Helmut Schaider’s works on UQ eSpace

181 works between 1991 and 2024
All (181) Journal Article (97) Conference Publication (84)

161 - 180 of 181 works

2003

Journal Article

Differential response of primary and metastatic melanomas to neutrophils attracted by IL-8

Schaider, Helmut, Oka, Masahiro, Bogenrieder, Thomas, Nesbit, Mark, Satyamoorthy, Kapaettu, Berking, Carola, Matsushima, Kouji and Herlyn, Meenhard (2003). Differential response of primary and metastatic melanomas to neutrophils attracted by IL-8. International Journal of Cancer, 103 (3), 335-343. doi: 10.1002/ijc.10775

Differential response of primary and metastatic melanomas to neutrophils attracted by IL-8

2001

Journal Article

Downregulation of E-cadherin and Desmoglein 1 by autocrine hepatocyte growth factor during melanoma development

Li, Gang, Schaider, Helmut, Satyamoorthy, Kapaettu, Hanakawa, Yasushi, Hashimoto, Koji and Herlyn, Meenhard (2001). Downregulation of E-cadherin and Desmoglein 1 by autocrine hepatocyte growth factor during melanoma development. Oncogene, 20 (56), 8125-8135. doi: 10.1038/sj.onc.1205034

Downregulation of E-cadherin and Desmoglein 1 by autocrine hepatocyte growth factor during melanoma development

2001

Journal Article

Transforming growth factor-beta 1 increases survival of human melanoma through stroma remodeling

Berking, C, Takemoto, R, Schaider, H, Showe, L, Satyamoorthy, K, Robbins, P and Herlyn, M (2001). Transforming growth factor-beta 1 increases survival of human melanoma through stroma remodeling. Cancer Research, 61 (22), 8306-8316.

Transforming growth factor-beta 1 increases survival of human melanoma through stroma remodeling

2001

Journal Article

alpha 5 and alpha 2 integrin gene transfers mimic the PDGF-B-induced transformed phenotype of fibroblasts in human skin

Nesbit, M, Schaider, H, Berking, C, Shih, DT, Hsu, MY, McBrian, M, Crombleholme, TM, Elenitsas, R, Buck, C and Herlyn, M (2001). alpha 5 and alpha 2 integrin gene transfers mimic the PDGF-B-induced transformed phenotype of fibroblasts in human skin. Laboratory Investigation, 81 (9), 1263-1274. doi: 10.1038/labinvest.3780340

alpha 5 and alpha 2 integrin gene transfers mimic the PDGF-B-induced transformed phenotype of fibroblasts in human skin

2001

Journal Article

Low-level monocyte chemoattractant protein-1 stimulation of monocytes leads to tumor formation in nontumorigenic melanoma cells

Nesbit, M, Schaider, H, Miller, TH and Herlyn, M (2001). Low-level monocyte chemoattractant protein-1 stimulation of monocytes leads to tumor formation in nontumorigenic melanoma cells. Journal of Immunology, 166 (11), 6483-6490. doi: 10.4049/jimmunol.166.11.6483

Low-level monocyte chemoattractant protein-1 stimulation of monocytes leads to tumor formation in nontumorigenic melanoma cells

2000

Journal Article

Interleukin-8 overexpression is present in pyoderma gangrenosum ulcers and leads to ulcer formation in human skin xenografts

Oka, M, Berking, C, Nesbit, M, Satyamoorthy, K, Schaider, H, Murphy, G, Ichihashi, M, Sauter, E and Herlyn, M (2000). Interleukin-8 overexpression is present in pyoderma gangrenosum ulcers and leads to ulcer formation in human skin xenografts. Laboratory Investigation, 80 (4), 595-604. doi: 10.1038/labinvest.3780064

Interleukin-8 overexpression is present in pyoderma gangrenosum ulcers and leads to ulcer formation in human skin xenografts

1998

Journal Article

CD44 and variants in melanocytic skin neoplasms

Schaider, H, Soyer, HP, Heider, KH, Hofmann-Wellenhof, R, Zatloukal, K, Smolle, J and Kerl, H (1998). CD44 and variants in melanocytic skin neoplasms. Journal of Cutaneous Pathology, 25 (4), 199-203. doi: 10.1111/j.1600-0560.1998.tb01719.x

CD44 and variants in melanocytic skin neoplasms

1998

Journal Article

Hexadecylphosphocholine inhibits invasion of mouse T-cell lymphoma cells in two different invasion assays

Schaider, H, Seidl, H, Berger, MR, Hofmann-Wellenhof, R, Tritthart, HA and Smolle, J (1998). Hexadecylphosphocholine inhibits invasion of mouse T-cell lymphoma cells in two different invasion assays. Anticancer Research, 18 (2A), 995-998.

Hexadecylphosphocholine inhibits invasion of mouse T-cell lymphoma cells in two different invasion assays

1997

Journal Article

Circulating adhesion molecules as prognostic factors for cutaneous melanoma

Schaider, H, RechWeichselbraun, I, Richtig, E, Seidl, H, Soyer, HP, Smolle, J and Kerl, H (1997). Circulating adhesion molecules as prognostic factors for cutaneous melanoma. Journal of the American Academy of Dermatology, 36 (2), 209-213. doi: 10.1016/S0190-9622(97)70282-2

Circulating adhesion molecules as prognostic factors for cutaneous melanoma

1997

Journal Article

Deletion analysis of the p16 tumor suppressor gene in gastrointestinal mucosa-associated lymphoid tissue lymphomas

Neumeister P., Hoefler G., Beham-Schmid C., Schmidt H., Apfelbeck U., Schaider H., Linkesch W. and Sill H. (1997). Deletion analysis of the p16 tumor suppressor gene in gastrointestinal mucosa-associated lymphoid tissue lymphomas. Gastroenterology, 112 (6), 1871-1875. doi: 10.1053/gast.1997.v112.pm9178679

Deletion analysis of the p16 tumor suppressor gene in gastrointestinal mucosa-associated lymphoid tissue lymphomas

1996

Journal Article

Hexadecylphosphocholine inhibits invasion of mouse T cell lymphoma cells in two different invasion assays

Schaider, H., Seidl, H., Hofmann-Wellenhof, R., Berger, M. R., Smolle, J. and Kerl, H. (1996). Hexadecylphosphocholine inhibits invasion of mouse T cell lymphoma cells in two different invasion assays. Skin Pharmacology, 9 (2).

Hexadecylphosphocholine inhibits invasion of mouse T cell lymphoma cells in two different invasion assays

1996

Conference Publication

CD44 standard and splice variants (v5 and v6) depression in melanocytic skin lesions.

Schaider, H, Heider, KH, Soyer, HP, Cerroni, L, Smolle, J and Kerl, H (1996). CD44 standard and splice variants (v5 and v6) depression in melanocytic skin lesions.. CAMBRIDGE: BLACKWELL SCIENCE INC.

CD44 standard and splice variants (v5 and v6) depression in melanocytic skin lesions.

1996

Journal Article

Application of α-aminoisobutyric acid, L-methionine, thymidine and 2-fluoro-2-deoxy-D-glucose to monitor effects of chemotherapy in a human colon carcinoma cell line

Schaider H., Haberkorn U., Berger M.R., Oberdorfer F., Morr I. and Van Kaick G. (1996). Application of α-aminoisobutyric acid, L-methionine, thymidine and 2-fluoro-2-deoxy-D-glucose to monitor effects of chemotherapy in a human colon carcinoma cell line. European Journal of Nuclear Medicine, 23 (1), 55-60. doi: 10.1007/BF01736990

Application of α-aminoisobutyric acid, L-methionine, thymidine and 2-fluoro-2-deoxy-D-glucose to monitor effects of chemotherapy in a human colon carcinoma cell line

1995

Journal Article

Dinaline inhibits amino acid transport and proliferation of colon carcinoma cells in vitro

Schaider, H, Haberkorn, U, Stohr, M and Berger, MR (1995). Dinaline inhibits amino acid transport and proliferation of colon carcinoma cells in vitro. Anticancer Research, 15 (6B), 2501-2509.

Dinaline inhibits amino acid transport and proliferation of colon carcinoma cells in vitro

1995

Conference Publication

No Difference in Levels of Soluble Human Icam-1, Pecam-1, Cd44 Standard, and Splice Variants V5, V6, and V10 in Patients with and Without Primary Tumors of Malignant-Melanoma (Pmm)

Schaider, H, Weichselbraun, I, Richtig, E, Smolle, J and Kerl, H (1995). No Difference in Levels of Soluble Human Icam-1, Pecam-1, Cd44 Standard, and Splice Variants V5, V6, and V10 in Patients with and Without Primary Tumors of Malignant-Melanoma (Pmm). BLACKWELL SCIENCE PUBL INC CAMBRIDGE.

No Difference in Levels of Soluble Human Icam-1, Pecam-1, Cd44 Standard, and Splice Variants V5, V6, and V10 in Patients with and Without Primary Tumors of Malignant-Melanoma (Pmm)

1995

Journal Article

Is there a correlation between cell cycle perturbations and chemosensitivity in ovarian cancer cells exposed to cytotoxic drugs in vitro?

Petru, E, Haas, J, Schaider, H and Sevin, BU (1995). Is there a correlation between cell cycle perturbations and chemosensitivity in ovarian cancer cells exposed to cytotoxic drugs in vitro?. Gynakologisch-Geburtshilfliche Rundschau, 35, 15-18.

Is there a correlation between cell cycle perturbations and chemosensitivity in ovarian cancer cells exposed to cytotoxic drugs in vitro?

1995

Journal Article

Combination treatment based on metabolic effects of dinaline

Schaider H., Haberkorn U., Petru E. and Berger M.R. (1995). Combination treatment based on metabolic effects of dinaline. Journal of Cancer Research and Clinical Oncology, 121 (4), 203-210. doi: 10.1007/BF01366963

Combination treatment based on metabolic effects of dinaline

1995

Journal Article

Korrelieren zellzyklus-verände-rungen von humanen ovarial-karzinomzellen nach exposition gegenüber zytostatika in vitro mit der zytotoxizität?

Petru, E., Haas, J., Schaider, H. and Sevin, B. U. (1995). Korrelieren zellzyklus-verände-rungen von humanen ovarial-karzinomzellen nach exposition gegenüber zytostatika in vitro mit der zytotoxizität?. Gynakologisch-geburtshilfliche Rundschau, 35 (1), 15-18. doi: 10.1159/000272557

Korrelieren zellzyklus-verände-rungen von humanen ovarial-karzinomzellen nach exposition gegenüber zytostatika in vitro mit der zytotoxizität?

1994

Conference Publication

Hexadecylphosphocholine Induces a Differential Pattern of Ki-Ras and Ha-Ras Expression in 2 Human Carcinoma Cell-Lines

Schaider, H, Peter, W, Fusenig, NE and Berger, MR (1994). Hexadecylphosphocholine Induces a Differential Pattern of Ki-Ras and Ha-Ras Expression in 2 Human Carcinoma Cell-Lines. BLACKWELL SCIENCE INC.

Hexadecylphosphocholine Induces a Differential Pattern of Ki-Ras and Ha-Ras Expression in 2 Human Carcinoma Cell-Lines

1992

Journal Article

Nongenital Cancers Metastatic to the Ovary

Petru, E, Pickel, H, Heydarfadai, M, Lahousen, M, Haas, J, Schaider, H and Tamussino, K (1992). Nongenital Cancers Metastatic to the Ovary. Gynecologic Oncology, 44 (1), 83-86. doi: 10.1016/0090-8258(92)90017-D

Nongenital Cancers Metastatic to the Ovary

Current funding

  • 2024 - 2026
    Preventing the cancer-promoting effects of tacrolimus on UV-treated keratinocytes
    Australasian College of Dermatologists Scientific Research Fund
    Open grant
  • 2024 - 2029
    Compound Discovery for Cancer Recurrence research
    Research Donation Generic
    Open grant
  • 2023 - 2026
    A calcium influx pathway regulates adaptive cancer drug tolerance
    NHMRC IDEAS Grants
    Open grant
  • 2022 - 2027
    The SiroSkin study: A multi-centre randomised double-blind placebo-controlled trial of 1% topical sirolimus in the chemoprevention of facial squamous cell carcinomas in solid organ... (Stream 7)
    NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
    Open grant

Past funding

  • 2023 - 2024
    A calcium influx pathway regulates adaptive cancer drug tolerance
    TdC Pioneering Grant
    Open grant
  • 2019 - 2022
    O-linked-N-acetylglucosamine transferase and ten-eleven translocation 1 facilitate therapy induced cellular reprogramming leading to acquired drug resistance in cancer
    Cancer Council Queensland
    Open grant
  • 2018 - 2022
    Improving outcomes for patients with melanoma brain metastases using novel personalised and response-adapted treatment strategies (PARF Translation Research Innovation Award administered by MSHHS)
    Metro South Hospital and Health Service
    Open grant
  • 2018
    Targeted and personalised early detection of melanoma using a 3D teledermatology network
    PA Research Foundation
    Open grant
  • 2017 - 2018
    Cutting-edge Imaging System for the Early Diagnosis of Face and Scalp Skin Cancer
    The Honda Foundation
    Open grant
  • 2017 - 2019
    Melanoma environment and heterogeneity in therapy sensitivity and resistance - Schaider
    Meehan Bequest
    Open grant
  • 2016 - 2019
    The role of chondroitin sulfate proteoglycan 4 (CSPG4) in the induction of multidruQ tolerance in melanoma cells (NO Forschung und Bildung funding led by Karl Landsteiner Uni for Med Sci)
    Karl Landsteiner University of Health Sciences
    Open grant
  • 2016
    Epigenetic remodelling driving acquired permanent drug resistance in melanoma cells
    PA Research Foundation
    Open grant
  • 2015 - 2021
    Centre of Research Excellence for the Study of Naevi
    NHMRC Centres of Research Excellence
    Open grant
  • 2015 - 2017
    Topical application of ORIL007 in two different mouse models
    Oncology Research International Ltd
    Open grant
  • 2015 - 2018
    Defining the role of Microphthalmia-associated Transcription Factor (MITF) in melanoma heterogeneity by real-time cell cycle imaging
    NHMRC Project Grant
    Open grant
  • 2015
    Next-generation cell analysis: Automated high-throughput 3D microscope and multimode microplate reader
    NHMRC Equipment Grant
    Open grant
  • 2014 - 2016
    Genetic polymorphisms associated with clinical and dermoscopic naevus signature patterns
    NHMRC Project Grant
    Open grant
  • 2014 - 2015
    Targeted expression of US28/GNA12/13 fusion proteins for cancer therapy
    UQ Collaboration and Industry Engagement Fund - Seed Research Grant
    Open grant

Availability

Associate Professor Helmut Schaider is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

Completed supervision

Enquiries

For media enquiries about Associate Professor Helmut Schaider's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au